Stocks Trending: InterDigital (NASDAQ:IDCC), Costamare (NYSE:CMRE), Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP), Infosys Limited (NYSE:INFY)

ChemoCentryx, Inc. (NASDAQ:CCXI) shares fell -0.25% in last trading session and ended the day at $4.07. CCXI has a return on assets of -47.00%. ChemoCentryx, Inc. (NASDAQ:CCXI) quarterly performance is -34.04%.

On 6 January, ChemoCentryx, Inc. (NASDAQ:CCXI) announced positive top-line data from its’ Phase II CLEAR trial with CCX168 in patients with anti-neutrophil cytoplasmic antibody (ANCA) -associated vasculitis, or AAV. CCX168 is a potent orally-administered small molecule that is a selective inhibitor of the complement C5a receptor, or C5aR. CCX168 is the lead drug candidate in the Company’s orphan and rare disease program.

InterDigital, Inc. (NASDAQ:IDCC) ended the last trading day at $44.96. Company weekly volatility is calculated as 2.62% and price to cash ratio as 1.84. InterDigital, Inc. (NASDAQ:IDCC) showed a weekly performance of -2.70%.

On 12 January, InterDigital, Inc. (NASDAQ:IDCC) announced that it has joined the Industrial Internet Consortium (IIC), a global non-profit, public-private partnership with over 200 member organizations.

On 14 January, Costamare Inc. (NYSE:CMRE) shares increased 1.59% and was closed at $7.67. CMRE EPS growth in last 5 year was -11.10%. Costamare Inc. (NYSE:CMRE) year to date (YTD) performance is -26.39%.

Costamare Inc (NASDAQ:CMRE) declared a quarterly dividend. Stockholders of record on Thursday, January 21st will be given a dividend of 0.29 per share on Thursday, February 4th. This represents a $1.16 annualized dividend and a dividend yield of 12.28%. The ex-dividend date of this dividend is Tuesday, January 19th.

Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) shares increased 1.19% in last trading session and ended the day at $5.10. TNXP has a return on assets of -83.90%. Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) quarterly performance is -24.56%.

Cantor Fitzgerald restated their buy rating on shares of Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)in a research report published on Tuesday, Analyst Ratings.Net reports.

Infosys Limited (NYSE:INFY) caters to the Technology space. It has a net profit margin of 22.30% and weekly performance is 11.15%. On the last day of trading company shares ended up at $17.85. Infosys Limited (NYSE:INFY) distance from 50-day simple moving average (SMA50) is 6.87%.

Infosys Limited (NYSE:INFY) has posted 6.6 per cent rise in net profit to Rs 3,465 crore for the quarter ended December 2015 as against Rs 3,250 crore in the same period last year on the back of a healthy volume growth. Infosys shares surged 4.28 per cent on the bourses after the company posted better results and upgraded revenue projection for the fiscal.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *